Drug Markups Reach Up To 2,000% In China
This article was originally published in PharmAsia News
Executive Summary
A CCTV survey shows that the pharmaceutical product clindamycin is selling at vastly different prices in Beijing and Shandong hospitals, with the gross margin reaching as high as 2,000% in some locations.